Wood M, Sweeney T, Trayah M, Civalier M, McMillian W. The Impact of Transitions of Care Pharmacist Services and Identification of Risk Predictors in Heart Failure Readmission. J Pharm Pract. 2019; 30:897

MacDougall J, Ahern J, Civalier M, Pierce K, Cohen R. Identification of Risk Factors for Initial Elevated Vancomycin Trough Concentrations. Journal of Pharmacy Technology 2016;32:289-33.

Redfern J, Wasilko S, Groth M, McMillian W, Bartlett C. Surgical Site Infections in Patients with Type III Open Fractures: Comparing Antibiotic Prophylaxis with Cefazolin plus Gentamicin versus Piperacillin/Tazobactam. Journal of Orthopaedic Trauma 2016;30:415-9.

Gonzalez J, Ahern J. Noyes E, Corriveau M, Mercier C. Identification of Risk Factors for Elevated Neonatal Gentamicin Trough Concentrations. Journal of Pediatric Pharmacology and Therapeutics 2016;21:133-9.

Barton C, McMillian W, Crookes B, et al. Compliance with Eastern Association for the Surgery of Trauma guidelines from prophylactic antibiotics after open extremity fracture. International Journal of Critical Illness and Injury Science 2012;2:96-101.

Mah N, Ahern J, Terhune C, et al. Interaction of Age and Levofloxacin Exposure on the Incidence of Clostridium Difficile Infection. Infectious Diseases in Clinical Practice 2011;19:262-4.

Bednarik JL, McMillian WD, Aloi JJ et al. Utility of ampicillin-sulbactam for empiric treatment of ventilator-associated pneumonia in a trauma population. The Journal of Trauma: Injury, Infection, and Critical Care 2010;69:861-5.

Van Meter D, Corriveau M, Ahern J, et al. A survey of once-daily dosage tobramycin therapy in patients with cystic fibrosis. Pediatric Pulmonology 2009;44:325-9.

Murphy C, Stevens A, Ferrentino N, et al. Frequency of Inappropriate Continuation of Acid Suppressive Therapy After Discharge in Patients Who Began Therapy in the Surgical Intensive Care Unit. Pharmacotherapy 2008;28:968-76.

Bessette E, Ahern J, Alston W. Risk Factors for Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia Despite Treatment with Vancomycin. Infectious Diseases in Clinical Practice 2007;15:174-7.

Nolin K, Murphy K, Ahern J, et al. Chempack program: Role of the health-system pharmacist. American Journal of Health System Pharmacy. 2006;63:2188-90.

Miller C, Rebuck J, Ahern J, et al. Daily Evaluation of Macroaspiration in the Critically ill Post-trauma Patient. Current Surgery 2005;5:504-7.

Mallow S, Rebuck J, Osler T, et al. Do Proton Pump Inhibitors Increase the Incidence of Nosocomial Pneumonia and Related Infectious Complications When Compared with Histamine-2 Receptor Antagonists in Critically ill Trauma Patients? Current Surgery 2004;61:452-7.

Niemic K, Corriveau M, Ahern J. Development of a Gentamicin and Tobramycin Strategy in the Neonatal Intensive Care Unit. Journal of Pediatric Pharmacology and Therapeutics 2004;3:192-196.

Ahern J, Lai C, Rebuck J, et al. Experience with Vancomycin in Patients Receiving Slow Low-Efficiency Dialysis. Hospital Pharmacy 2004;39:138-142.

Daley R, Rebuck J, Welage L, et al.. Prevention of stress ulceration: Current trends in critical care. Critical Care Medicine 2004;312:2008-12.